CurrentRheuma
Get Weekly

Topic

Inflammatory myopathies

Dermatomyositis, polymyositis, antisynthetase syndrome, immune-mediated necrotizing myopathy, inclusion body myositis, myositis-specific antibodies, myositis-associated interstitial lung disease and cancer-associated myositis

CurrentRheuma holds 430 Briefs in Inflammatory myopathies, most often cohort studies and cross-sectional studies; the journals with the most are Rheumatology (Oxford), Clin Exp Rheumatol and Semin Arthritis Rheum.

430 Briefs placed here27 more Briefs indexed under this topic as a secondary topic

Briefs in Inflammatory myopathies

Newest publication first

  1. Rheumatology (Oxford)

    Urinary β2-microglobulin as a prognostic and treatment-associated biomarker in anti-MDA5 antibody-positive DM with interstitial lung disease

    Diagnostic or prognostic study

  2. Joint Bone Spine

    Normal Creatine Kinase in Idiopathic Inflammatory Myopathies: Disease Characteristics and Outcomes

    Secondary analysis

  3. Rheumatology (Oxford)

    Rituximab for the treatment of calcinosis in dermatomyositis: A case series and review of the literature

    Cohort study

  4. Ann Rheum Dis

    Spatial transcriptomics in immune-mediated necrotising myopathy uncovers a specific necrotic signature related to immune-driven fibrosis

    Research article

  5. Rheumatology (Oxford)

    Risk stratification of severe infections after remission induction therapy in idiopathic inflammatory myopathy: a multicentre MYKO study

    Diagnostic or prognostic study

  6. Rheumatology (Oxford)

    Epidemiology, autoimmune overlap and in-hospital outcomes of idiopathic inflammatory myopathies in Spain, 1997–2024

    Cohort study

  7. Arthritis Care Res (Hoboken)

    Pain Phenotypes in Patients With Inflammatory Myopathies: A Latent Class Analysis

    Cross-sectional study

  8. Semin Arthritis Rheum

    Premature ageing in myositis: Impairments in physical function, muscle power and body composition

    Cross-sectional study

  9. Arthritis Rheumatol

    Plasma Proteome Reflects Tissue Damage and Clinical Manifestations in Patients With Inflammatory Myopathies

    Cross-sectional study

  10. Lancet Rheumatol

    Minimal residual disease flow cytometry of peripheral blood B-cell subsets in patients with idiopathic inflammatory myopathies following rituximab therapy: a single-centre, retrospective cohort study

    Cohort study

  11. Rheumatology (Oxford)

    Anti-Ro52 antibodies in idiopathic inflammatory myopathies: clinical significance across myositis-specific antibody–defined subgroups

    Cohort study

  12. Rheumatology (Oxford)

    Real-world experience with obinutuzumab in difficult-to-treat myositis: concise report of a case series

    Cohort study

  13. Rheumatology (Oxford)

    Self-efficacy in idiopathic inflammatory myopathies: associated factors, profiles and patient-reported outcomes

    Cross-sectional study

  14. Rheumatology (Oxford)

    Different age, different phenotype: a comparative analysis of juvenile and adult-onset dermatomyositis from a tertiary centre

    Cohort study

  15. Arthritis Care Res (Hoboken)

    Clinical Characteristics and Concordance of Anti‐ MDA5 Antibodies: A Multicenter Australian Study

    Cohort study

  16. Rheumatology (Oxford)

    Mediterranean diet and health outcomes in idiopathic inflammatory myopathies

    Cross-sectional study

  17. Semin Arthritis Rheum

    Cancer-associated myositis in Chinese patients with idiopathic inflammatory myopathies: Malignancy spectrum, risk factors, and validation of the IMACS guideline

    Cohort study

  18. Semin Arthritis Rheum

    Effectiveness and safety of upadacitinib on adult dermatomyositis: a cohort study in China

    Cohort study

  19. J Rheumatol

    Clinical Meaningfulness and Improvement Thresholds of Myositis Core Set Measures: Association With Patient-Reported Outcomes

    Cohort study

  20. Semin Arthritis Rheum

    Clinical characteristics of patients with antisynthetase syndrome and dermatomyositis-type skin involvement: Insights from the Myo-Spain registry

    Cross-sectional study

  21. RMD Open

    Characteristics and outcomes of anti-Ku antibody–associated interstitial lung disease: a retrospective study of 60 patients

    Cohort study

  22. Ann Rheum Dis

    Spatial transcriptomics reveals mechanism of autoimmunity driven by internalised autoantibodies

    Mechanistic study

  23. Arthritis Res Ther

    Dysregulated IL-6 pathway activity in idiopathic inflammatory myopathies

    Mechanistic study

  24. Rheumatology (Oxford)

    Nutritional interventions and dietary supplements in muscle diseases: a systematic review

    Meta-analysis

  25. RMD Open

    Epidemiology of idiopathic inflammatory myopathies: a population-based cohort in England, 2002–2021

    Cohort study

  26. RMD Open

    Evaluation of the prognostic value of visual and quantitative CT analysis in myositis-associated interstitial lung disease

    Cohort study

  27. RMD Open

    Multicentre international audit of IMACS malignancy screening guidelines in idiopathic inflammatory myopathies: insights from the myositis audit and research collaborative group

    Cohort study

  28. Arthritis Res Ther

    Alterations in systemic and skeletal muscle myostatin regulation are most prominent at disease onset and associate with muscle-related outcomes in idiopathic inflammatory myopathies

    Cohort study

  29. Rheumatology (Oxford)

    Predictors of rapidly progressive interstitial lung disease in anti-MDA5 dermatomyositis: a meta-analysis

    Meta-analysis

  30. Semin Arthritis Rheum

    Adult-onset dermatomyositis is associated with an increased prevalence of diabetes mellitus independent of glucocorticoid use,

    Cohort study

  31. Rheumatology (Oxford)

    Gastrointestinal involvement in dermatomyositis: multicentric retrospective cohort study

    Cohort study

  32. Rheumatology (Oxford)

    Concordance for myositis-specific autoantibody detection between commercial ELISA and line blot assays: a multicentre study conducted across the Asia-Pacific region

    Diagnostic or prognostic study

  33. J Rheumatol

    Does the ACR/EULAR Total Improvement Score Reflect How Individuals With Autoimmune Inflammatory Myopathies Feel and Function?

    Cohort study

  34. Arthritis Care Res (Hoboken)

    Immunogenicity, Safety, and Determinants of Recombinant Zoster Vaccine Response in Idiopathic Inflammatory Myopathies: A Phase 4 Randomized Trial

    Secondary analysis

  35. Rheumatology (Oxford)

    Patient–physician discordance in idiopathic inflammatory myopathies: a longitudinal analysis of links to disease activity and damage

    Cohort study

  36. Arthritis Rheumatol

    Development and Validation of the ALARN Model: A Predictive Mortality Score for Antisynthetase Syndrome

    Cohort study

  37. Arthritis Res Ther

    Site-level cutaneous phenotyping framework for anti-MDA5-positive dermatomyositis: exploratory associations with systemic immune reference markers

    Cross-sectional study

  38. Semin Arthritis Rheum

    Evaluation of physical function in patients with inflammatory myopathies using the health assessment questionnaire-II (HAQ-II)

    Diagnostic or prognostic study

  39. RMD Open

    Serum KL-6 and lung ultrasound B-lines: a combined non-invasive model for screening and predicting interstitial lung disease in idiopathic inflammatory myopathy

    Diagnostic or prognostic study

  40. Arthritis Res Ther

    Elevated sST2 associates with cardiac involvement and declines after treatment in newly diagnosed patients with idiopathic inflammatory myopathies

    Cohort study

All 430 Briefs in ExploreShowing the 40 most recently published